ID   AT2B4_HUMAN             Reviewed;        1241 AA.
AC   P23634; B1APW5; B1APW6; Q13450; Q13452; Q13455; Q16817; Q7Z3S1;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   10-MAY-2017, entry version 183.
DE   RecName: Full=Plasma membrane calcium-transporting ATPase 4 {ECO:0000305};
DE            Short=PMCA4 {ECO:0000303|PubMed:1531651, ECO:0000312|EMBL:AAA50819.1};
DE            EC=3.6.3.8 {ECO:0000269|PubMed:8530416};
DE   AltName: Full=Matrix-remodeling-associated protein 1;
DE   AltName: Full=Plasma membrane calcium ATPase isoform 4;
DE   AltName: Full=Plasma membrane calcium pump isoform 4;
GN   Name=ATP2B4 {ECO:0000312|HGNC:HGNC:817}; Synonyms=ATP2B2, MXRA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM XB), PARTIAL PROTEIN SEQUENCE, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Erythrocyte;
RX   PubMed=2137451;
RA   Strehler E.E., James P., Fischer R., Heim R., Vorherr T.E.,
RA   Filoteo A.G., Penniston J.T., Carafoli E.;
RT   "Peptide sequence analysis and molecular cloning reveal two calcium
RT   pump isoforms in the human erythrocyte membrane.";
RL   J. Biol. Chem. 265:2835-2842(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM XA), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=1531651;
RA   Brandt P., Neve R.L., Kammesheidt A., Rhoads R.E., Vanaman T.C.;
RT   "Analysis of the tissue-specific distribution of mRNAs encoding the
RT   plasma membrane calcium-pumping ATPases and characterization of an
RT   alternately spliced form of PMCA4 at the cDNA and genomic levels.";
RL   J. Biol. Chem. 267:4376-4385(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM XB).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM XA).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS XA; XB; XK; ZA; ZB AND
RP   ZK).
RC   TISSUE=Heart muscle;
RX   PubMed=8700162; DOI=10.1007/BF00229314;
RA   Santiago-Garcia J., Mas-Oliva J., Saavedra D., Zarain-Herzberg A.;
RT   "Analysis of mRNA expression and cloning of a novel plasma membrane
RT   Ca(2+)-ATPase splice variant in human heart.";
RL   Mol. Cell. Biochem. 155:173-182(1996).
RN   [8]
RP   PROTEIN SEQUENCE OF 1085-1153 (ISOFORMS XB/ZB), AND CALMODULIN-BINDING
RP   SUBDOMAIN A.
RX   PubMed=2963820;
RA   James P., Maeda M., Fischer R., Verma A.K., Krebs J., Penniston J.T.,
RA   Carafoli E.;
RT   "Identification and primary structure of a calmodulin binding domain
RT   of the Ca2+ pump of human erythrocytes.";
RL   J. Biol. Chem. 263:2905-2910(1988).
RN   [9]
RP   PROTEIN SEQUENCE OF 1177-1190.
RX   PubMed=2966397; DOI=10.1073/pnas.85.9.2914;
RA   Brandt P., Zurini M., Neve R.L., Rhoads R.E., Vanaman T.C.;
RT   "A C-terminal, calmodulin-like regulatory domain from the plasma
RT   membrane Ca2+-pumping ATPase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2914-2918(1988).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS X AND Z).
RC   TISSUE=Heart;
RX   PubMed=8245032;
RA   Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.;
RT   "Quantitative analysis of alternative splicing options of human plasma
RT   membrane calcium pump genes.";
RL   J. Biol. Chem. 268:25993-26003(1993).
RN   [11]
RP   ERRATUM.
RX   PubMed=7989379;
RA   Stauffer T.P., Hilfiker H., Carafoli E., Strehler E.E.;
RL   J. Biol. Chem. 269:32022-32022(1994).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, AND MUTAGENESIS OF
RP   ASP-672; VAL-674; ARG-675; LYS-686 AND ARG-693.
RX   PubMed=8530416; DOI=10.1074/jbc.270.50.30111;
RA   Adamo H.P., Filoteo A.G., Enyedi A., Penniston J.T.;
RT   "Mutants in the putative nucleotide-binding region of the plasma
RT   membrane Ca(2+)-pump. A reduction in activity due to slow
RT   dephosphorylation.";
RL   J. Biol. Chem. 270:30111-30114(1995).
RN   [13]
RP   INTERACTION WITH PDZD11.
RX   PubMed=12763866; DOI=10.1111/j.1749-6632.2003.tb07230.x;
RA   Goellner G.M., DeMarco S.J., Strehler E.E.;
RT   "Characterization of PISP, a novel single-PDZ protein that binds to
RT   all plasma membrane Ca2+-ATPase b-splice variants.";
RL   Ann. N. Y. Acad. Sci. 986:461-471(2003).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   INTERACTION WITH SLC35G1 AND STIM1.
RX   PubMed=22084111; DOI=10.1073/pnas.1117231108;
RA   Krapivinsky G., Krapivinsky L., Stotz S.C., Manasian Y., Clapham D.E.;
RT   "POST, partner of stromal interaction molecule 1 (STIM1), targets
RT   STIM1 to multiple transporters.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:19234-19239(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13 AND SER-328, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-13, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   STRUCTURE BY NMR OF 1086-1104 IN COMPLEX WITH CALMODULIN.
RX   PubMed=10493800; DOI=10.1021/bi9908235;
RA   Elshorst B., Hennig M., Foersterling H., Diener A., Maurer M.,
RA   Schulte P., Schwalbe H., Griesinger C., Krebs J., Schmid H.,
RA   Vorherr T.E., Carafoli E.;
RT   "NMR solution structure of a complex of calmodulin with a binding
RT   peptide of the Ca(2+) pump.";
RL   Biochemistry 38:12320-12332(1999).
CC   -!- FUNCTION: Calcium/calmodulin-regulated and magnesium-dependent
CC       enzyme that catalyzes the hydrolysis of ATP coupled with the
CC       transport of calcium out of the cell (PubMed:8530416). By
CC       regulating sperm cell calcium homeostasis, may play a role in
CC       sperm motility (By similarity). {ECO:0000250|UniProtKB:Q6Q477,
CC       ECO:0000269|PubMed:8530416}.
CC   -!- CATALYTIC ACTIVITY: ATP + H(2)O + Ca(2+)(Side 1) = ADP + phosphate
CC       + Ca(2+)(Side 2). {ECO:0000269|PubMed:8530416}.
CC   -!- ENZYME REGULATION: Activated by calcium/calmodulin.
CC       {ECO:0000269|PubMed:8530416}.
CC   -!- SUBUNIT: Interacts with PDZD11 (PubMed:12763866). Interacts with
CC       SLC35G1 and STIM1 (PubMed:22084111). Interacts with calmodulin
CC       (PubMed:2963820, PubMed:10493800). {ECO:0000269|PubMed:10493800,
CC       ECO:0000269|PubMed:12763866, ECO:0000269|PubMed:22084111,
CC       ECO:0000269|PubMed:2963820}.
CC   -!- INTERACTION:
CC       P01258:CALCA; NbExp=2; IntAct=EBI-1174388, EBI-1018474;
CC       Q63622:Dlg2 (xeno); NbExp=2; IntAct=EBI-1174437, EBI-396947;
CC       Q62936:Dlg3 (xeno); NbExp=2; IntAct=EBI-1174437, EBI-349596;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:2137451};
CC       Multi-pass membrane protein {ECO:0000255}. Cell projection,
CC       cilium, flagellum membrane {ECO:0000250|UniProtKB:Q6Q477}; Multi-
CC       pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC         Comment=There is a combination of two alternatively spliced
CC         domains at N-terminal site A (X and Z) and at C-terminal site
CC         B/C (A, B, D and K). The splice sites have mostly been studied
CC         independently. Full isoforms so far detected are isoform XA and
CC         isoform XB. Experimental confirmation may be lacking for some
CC         isoforms.;
CC       Name=XD; Synonyms=AIICIV;
CC         IsoId=P23634-1; Sequence=Displayed;
CC       Name=XA; Synonyms=AIICII;
CC         IsoId=P23634-2; Sequence=VSP_000405;
CC       Name=ZA; Synonyms=AICII;
CC         IsoId=P23634-3; Sequence=VSP_000402, VSP_000405;
CC       Name=XK; Synonyms=XG;
CC         IsoId=P23634-4; Sequence=VSP_000403, VSP_000405;
CC       Name=ZK; Synonyms=ZG;
CC         IsoId=P23634-5; Sequence=VSP_000402, VSP_000403, VSP_000405;
CC       Name=XB; Synonyms=AIICI, hPMCA4b;
CC         IsoId=P23634-6; Sequence=VSP_000404;
CC       Name=ZB; Synonyms=AICI;
CC         IsoId=P23634-7; Sequence=VSP_000402, VSP_000404;
CC       Name=ZD; Synonyms=AICIV;
CC         IsoId=P23634-8; Sequence=VSP_000402;
CC   -!- TISSUE SPECIFICITY: Isoform XB is the most abundant isoform and is
CC       expressed ubiquitously. Isoforms containing segment Z have only
CC       been detected in heart, while isoforms containing segment a have
CC       been found in heart, stomach and brain cortex.
CC       {ECO:0000269|PubMed:1531651}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type)
CC       (TC 3.A.3) family. Type IIB subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M25874; AAA50819.1; -; mRNA.
DR   EMBL; M83363; AAA36455.1; -; mRNA.
DR   EMBL; BX537444; CAD97686.1; -; mRNA.
DR   EMBL; U42026; AAB17577.1; -; mRNA.
DR   EMBL; U42061; AAB17578.1; -; mRNA.
DR   EMBL; U42062; AAB17579.1; -; mRNA.
DR   EMBL; U42378; AAB17580.1; -; mRNA.
DR   EMBL; AL513343; CAI17025.1; -; Genomic_DNA.
DR   EMBL; AC114402; CAI17025.1; JOINED; Genomic_DNA.
DR   EMBL; AL513343; CAI17026.1; -; Genomic_DNA.
DR   EMBL; AC114402; CAI17026.1; JOINED; Genomic_DNA.
DR   EMBL; CH471067; EAW91483.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91486.1; -; Genomic_DNA.
DR   EMBL; BC140774; AAI40775.1; -; mRNA.
DR   CCDS; CCDS1440.1; -. [P23634-6]
DR   CCDS; CCDS30977.1; -. [P23634-2]
DR   PIR; A35547; A35547.
DR   RefSeq; NP_001001396.1; NM_001001396.2. [P23634-2]
DR   RefSeq; NP_001675.3; NM_001684.4. [P23634-6]
DR   UniGene; Hs.343522; -.
DR   UniGene; Hs.733333; -.
DR   PDB; 1CFF; NMR; -; B=1086-1104.
DR   PDB; 2KNE; NMR; -; B=1086-1149.
DR   PDBsum; 1CFF; -.
DR   PDBsum; 2KNE; -.
DR   ProteinModelPortal; P23634; -.
DR   SMR; P23634; -.
DR   BioGrid; 106983; 49.
DR   DIP; DIP-6128N; -.
DR   IntAct; P23634; 22.
DR   MINT; MINT-219327; -.
DR   STRING; 9606.ENSP00000350310; -.
DR   TCDB; 3.A.3.2.1; the p-type atpase (p-atpase) superfamily.
DR   iPTMnet; P23634; -.
DR   PhosphoSitePlus; P23634; -.
DR   SwissPalm; P23634; -.
DR   BioMuta; ATP2B4; -.
DR   DMDM; 14286105; -.
DR   EPD; P23634; -.
DR   MaxQB; P23634; -.
DR   PaxDb; P23634; -.
DR   PeptideAtlas; P23634; -.
DR   PRIDE; P23634; -.
DR   DNASU; 493; -.
DR   Ensembl; ENST00000341360; ENSP00000340930; ENSG00000058668. [P23634-2]
DR   Ensembl; ENST00000357681; ENSP00000350310; ENSG00000058668. [P23634-6]
DR   Ensembl; ENST00000367218; ENSP00000356187; ENSG00000058668. [P23634-2]
DR   GeneID; 493; -.
DR   KEGG; hsa:493; -.
DR   UCSC; uc001gzv.4; human. [P23634-1]
DR   CTD; 493; -.
DR   DisGeNET; 493; -.
DR   GeneCards; ATP2B4; -.
DR   HGNC; HGNC:817; ATP2B4.
DR   HPA; CAB016118; -.
DR   HPA; HPA040431; -.
DR   MIM; 108732; gene.
DR   neXtProt; NX_P23634; -.
DR   OpenTargets; ENSG00000058668; -.
DR   PharmGKB; PA25110; -.
DR   eggNOG; KOG0204; Eukaryota.
DR   eggNOG; ENOG410XNNC; LUCA.
DR   GeneTree; ENSGT00510000046331; -.
DR   HOVERGEN; HBG061286; -.
DR   InParanoid; P23634; -.
DR   KO; K05850; -.
DR   OMA; LNNNVFI; -.
DR   PhylomeDB; P23634; -.
DR   TreeFam; TF300330; -.
DR   Reactome; R-HSA-418359; Reduction of cytosolic Ca++ levels.
DR   Reactome; R-HSA-5578775; Ion homeostasis.
DR   Reactome; R-HSA-936837; Ion transport by P-type ATPases.
DR   ChiTaRS; ATP2B4; human.
DR   EvolutionaryTrace; P23634; -.
DR   GeneWiki; ATP2B4; -.
DR   GenomeRNAi; 493; -.
DR   PRO; PR:P23634; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000058668; -.
DR   CleanEx; HS_ATP2B2; -.
DR   CleanEx; HS_ATP2B4; -.
DR   ExpressionAtlas; P23634; baseline and differential.
DR   Genevisible; P23634; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005901; C:caveola; TAS:BHF-UCL.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0043234; C:protein complex; ISS:BHF-UCL.
DR   GO; GO:0036126; C:sperm flagellum; ISS:UniProtKB.
DR   GO; GO:0097228; C:sperm principal piece; IEA:Ensembl.
DR   GO; GO:0030315; C:T-tubule; IDA:BHF-UCL.
DR   GO; GO:0030018; C:Z disc; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005388; F:calcium-transporting ATPase activity; IMP:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; IPI:BHF-UCL.
DR   GO; GO:0036487; F:nitric-oxide synthase inhibitor activity; IDA:BHF-UCL.
DR   GO; GO:0030165; F:PDZ domain binding; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0030346; F:protein phosphatase 2B binding; IDA:BHF-UCL.
DR   GO; GO:0097110; F:scaffold protein binding; ISS:BHF-UCL.
DR   GO; GO:1901660; P:calcium ion export; IEA:Ensembl.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; IC:BHF-UCL.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; IC:BHF-UCL.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:BHF-UCL.
DR   GO; GO:0006874; P:cellular calcium ion homeostasis; IDA:BHF-UCL.
DR   GO; GO:0071872; P:cellular response to epinephrine stimulus; IDA:BHF-UCL.
DR   GO; GO:0030317; P:flagellated sperm motility; ISS:UniProtKB.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0034220; P:ion transmembrane transport; TAS:Reactome.
DR   GO; GO:1901205; P:negative regulation of adrenergic receptor signaling pathway involved in heart process; IDA:BHF-UCL.
DR   GO; GO:1900082; P:negative regulation of arginine catabolic process; IDA:BHF-UCL.
DR   GO; GO:0070885; P:negative regulation of calcineurin-NFAT signaling cascade; IDA:BHF-UCL.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; IMP:BHF-UCL.
DR   GO; GO:1903249; P:negative regulation of citrulline biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0045019; P:negative regulation of nitric oxide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010751; P:negative regulation of nitric oxide mediated signal transduction; IDA:BHF-UCL.
DR   GO; GO:0051001; P:negative regulation of nitric-oxide synthase activity; IDA:BHF-UCL.
DR   GO; GO:1902083; P:negative regulation of peptidyl-cysteine S-nitrosylation; NAS:BHF-UCL.
DR   GO; GO:0098736; P:negative regulation of the force of heart contraction; IDA:BHF-UCL.
DR   GO; GO:0003407; P:neural retina development; IEA:Ensembl.
DR   GO; GO:2000481; P:positive regulation of cAMP-dependent protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IDA:BHF-UCL.
DR   GO; GO:1903779; P:regulation of cardiac conduction; TAS:Reactome.
DR   GO; GO:1902806; P:regulation of cell cycle G1/S phase transition; IMP:CACAO.
DR   GO; GO:1902305; P:regulation of sodium ion transmembrane transport; IC:BHF-UCL.
DR   GO; GO:0006357; P:regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0051599; P:response to hydrostatic pressure; IMP:BHF-UCL.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   Gene3D; 1.20.1110.10; -; 3.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   InterPro; IPR034304; ATP2B4.
DR   InterPro; IPR022141; ATP_Ca_trans_C.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_domN.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006408; P-type_ATPase_IIB.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   PANTHER; PTHR24093:SF380; PTHR24093:SF380; 1.
DR   Pfam; PF12424; ATP_Ca_trans_C; 2.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   Pfam; PF00122; E1-E2_ATPase; 2.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 2.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   TIGRFAMs; TIGR01517; ATPase-IIB_Ca; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 3.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Calcium;
KW   Calcium transport; Calmodulin-binding; Cell membrane; Cell projection;
KW   Complete proteome; Direct protein sequencing; Hydrolase;
KW   Ion transport; Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1   1241       Plasma membrane calcium-transporting
FT                                ATPase 4.
FT                                /FTId=PRO_0000046220.
FT   TOPO_DOM      1     92       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     93    113       Helical. {ECO:0000255}.
FT   TOPO_DOM    114    150       Extracellular. {ECO:0000255}.
FT   TRANSMEM    151    171       Helical. {ECO:0000255}.
FT   TOPO_DOM    172    356       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    357    376       Helical. {ECO:0000255}.
FT   TOPO_DOM    377    409       Extracellular. {ECO:0000255}.
FT   TRANSMEM    410    427       Helical. {ECO:0000255}.
FT   TOPO_DOM    428    840       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    841    860       Helical. {ECO:0000255}.
FT   TOPO_DOM    861    870       Extracellular. {ECO:0000255}.
FT   TRANSMEM    871    891       Helical. {ECO:0000255}.
FT   TOPO_DOM    892    911       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    912    934       Helical. {ECO:0000255}.
FT   TOPO_DOM    935    952       Extracellular. {ECO:0000255}.
FT   TRANSMEM    953    974       Helical. {ECO:0000255}.
FT   TOPO_DOM    975    993       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    994   1015       Helical. {ECO:0000255}.
FT   TOPO_DOM   1016   1025       Extracellular. {ECO:0000255}.
FT   TRANSMEM   1026   1047       Helical. {ECO:0000255}.
FT   TOPO_DOM   1048   1241       Cytoplasmic. {ECO:0000255}.
FT   REGION     1086   1103       Calmodulin-binding subdomain A.
FT                                {ECO:0000269|PubMed:2963820}.
FT   REGION     1104   1113       Calmodulin-binding subdomain B.
FT                                {ECO:0000250|UniProtKB:P20020}.
FT   ACT_SITE    465    465       4-aspartylphosphate intermediate.
FT                                {ECO:0000250|UniProtKB:P19156}.
FT   METAL       785    785       Magnesium. {ECO:0000250}.
FT   METAL       789    789       Magnesium. {ECO:0000250}.
FT   MOD_RES      13     13       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     328    328       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1102   1102       Phosphothreonine; by PKC. {ECO:0000250}.
FT   VAR_SEQ     301    312       Missing (in isoform ZA, isoform ZK,
FT                                isoform ZB and isoform ZD).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000402.
FT   VAR_SEQ    1009   1044       Missing (in isoform XK and isoform ZK).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_000403.
FT   VAR_SEQ    1104   1139       Missing (in isoform XB and isoform ZB).
FT                                {ECO:0000303|PubMed:17974005,
FT                                ECO:0000303|PubMed:2137451}.
FT                                /FTId=VSP_000404.
FT   VAR_SEQ    1140   1241       IKVVKAFHSSLHESIQKPYNQKSIHSFMTHPEFAIEEELPR
FT                                TPLLDEEEEENPDKASKFGTRVLLLDGEVTPYANTNNNAVD
FT                                CNQVQLPQSDSSLQSLETSV -> VAVAPVKSSPTTSVPAV
FT                                SSPPMGNQSGQSVP (in isoform XA, isoform
FT                                XK, isoform ZA and isoform ZK).
FT                                {ECO:0000303|PubMed:1531651,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000405.
FT   MUTAGEN     672    672       D->Q: Strongly decreased calcium
FT                                transport activity. Slowed decomposition
FT                                of the phosphorylated intermediate.
FT                                {ECO:0000269|PubMed:8530416}.
FT   MUTAGEN     674    674       V->P: Decreased calcium transport
FT                                activity. {ECO:0000269|PubMed:8530416}.
FT   MUTAGEN     675    675       R->K,D,L: Decreased calcium transport
FT                                activity. {ECO:0000269|PubMed:8530416}.
FT   MUTAGEN     686    686       K->L: Decreased calcium transport
FT                                activity. {ECO:0000269|PubMed:8530416}.
FT   MUTAGEN     693    693       R->I: Mildly decreased calcium transport
FT                                activity. {ECO:0000269|PubMed:8530416}.
FT   CONFLICT    492    492       S -> C (in Ref. 3; CAD97686).
FT                                {ECO:0000305}.
FT   CONFLICT   1144   1144       K -> N (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1147   1147       H -> S (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1153   1153       S -> F (in Ref. 8; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1178   1178       L -> Q (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1187   1187       E -> Q (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT   1190   1190       E -> G (in Ref. 3; CAD97686).
FT                                {ECO:0000305}.
FT   TURN       1087   1089       {ECO:0000244|PDB:2KNE}.
FT   TURN       1090   1092       {ECO:0000244|PDB:1CFF}.
FT   HELIX      1093   1102       {ECO:0000244|PDB:1CFF}.
FT   HELIX      1141   1147       {ECO:0000244|PDB:2KNE}.
SQ   SEQUENCE   1241 AA;  137920 MW;  568544103CD5F494 CRC64;
     MTNPSDRVLP ANSMAESREG DFGCTVMELR KLMELRSRDA LTQINVHYGG VQNLCSRLKT
     SPVEGLSGNP ADLEKRRQVF GHNVIPPKKP KTFLELVWEA LQDVTLIILE IAAIISLVLS
     FYRPAGEENE LCGQVATTPE DENEAQAGWI EGAAILFSVI IVVLVTAFND WSKEKQFRGL
     QCRIEQEQKF SIIRNGQLIQ LPVAEIVVGD IAQVKYGDLL PADGILIQGN DLKIDESSLT
     GESDHVKKSL DKDPMLLSGT HVMEGSGRMV VTAVGVNSQT GIILTLLGVN EDDEGEKKKK
     GKKQGVPENR NKAKTQDGVA LEIQPLNSQE GIDNEEKDKK AVKVPKKEKS VLQGKLTRLA
     VQIGKAGLLM SALTVFILIL YFVIDNFVIN RRPWLPECTP IYIQYFVKFF IIGITVLVVA
     VPEGLPLAVT ISLAYSVKKM MKDNNLVRHL DACETMGNAT AICSDKTGTL TMNRMTVVQA
     YIGGIHYRQI PSPDVFLPKV LDLIVNGISI NSAYTSKILP PEKEGGLPRQ VGNKTECALL
     GFVTDLKQDY QAVRNEVPEE KLYKVYTFNS VRKSMSTVIR NPNGGFRMYS KGASEIILRK
     CNRILDRKGE AVPFKNKDRD DMVRTVIEPM ACDGLRTICI AYRDFDDTEP SWDNENEILT
     ELTCIAVVGI EDPVRPEVPD AIAKCKQAGI TVRMVTGDNI NTARAIATKC GILTPGDDFL
     CLEGKEFNRL IRNEKGEVEQ EKLDKIWPKL RVLARSSPTD KHTLVKGIID STVGEHRQVV
     AVTGDGTNDG PALKKADVGF AMGIAGTDVA KEASDIILTD DNFTSIVKAV MWGRNVYDSI
     SKFLQFQLTV NVVAVIVAFT GACITQDSPL KAVQMLWVNL IMDTFASLAL ATEPPTESLL
     KRRPYGRNKP LISRTMMKNI LGHAFYQLIV IFILVFAGEK FFDIDSGRKA PLHSPPSQHY
     TIVFNTFVLM QLFNEINSRK IHGEKNVFSG IYRNIIFCSV VLGTFICQIF IVEFGGKPFS
     CTSLSLSQWL WCLFIGIGEL LWGQFISAIP TRSLKFLKEA GHGTTKEEIT KDAEGLDEID
     HAEMELRRGQ ILWFRGLNRI QTQIDVINTF QTGASFKGVL RRQNMGQHLD VKLVPSSSYI
     KVVKAFHSSL HESIQKPYNQ KSIHSFMTHP EFAIEEELPR TPLLDEEEEE NPDKASKFGT
     RVLLLDGEVT PYANTNNNAV DCNQVQLPQS DSSLQSLETS V
//
